SEC CIK 1412667
Kirby Lynelle P
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| ULTAview stock → | 870,723 | 2011-01-06 |
Position History — ULTA
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — ULTA
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2011-01-06 | Option exercise (derivative) | 44,196 | $0.00 | 100,000 |
| 2011-01-06 | Open-market sale | 44,196 | $35.01 | 870,723 |
| 2011-01-06 | Option exercise | 44,196 | $10.34 | 914,919 |
| 2010-12-23 | Option exercise (derivative) | 5,404 | $0.00 | 144,196 |
| 2010-12-23 | Open-market sale | 5,404 | $34.97 | 870,723 |
| 2010-12-23 | Option exercise | 5,404 | $10.34 | 876,127 |
| 2010-12-13 | Option exercise (derivative) | 400 | $0.00 | 149,600 |
| 2010-12-13 | Option exercise (derivative) | 40,000 | $0.00 | 0 |
| 2010-12-13 | Option exercise | 400 | $10.34 | 871,123 |
| 2010-12-13 | Open-market sale | 40,000 | $34.96 | 870,723 |
| 2010-12-13 | Option exercise | 40,000 | $15.81 | 910,723 |
| 2010-12-10 | Option exercise (derivative) | 7,700 | $0.00 | 40,000 |
| 2010-12-10 | Open-market sale | 7,700 | $34.93 | 870,723 |
| 2010-12-10 | Option exercise | 7,700 | $15.81 | 878,423 |
| 2010-12-09 | Option exercise (derivative) | 18,300 | $0.00 | 47,700 |
| 2010-12-09 | Option exercise (derivative) | 50,000 | $0.00 | 150,000 |
| 2010-12-09 | Option exercise | 50,000 | $10.34 | 920,723 |
| 2010-12-09 | Option exercise | 18,300 | $15.81 | 889,023 |
| 2010-12-09 | Open-market sale | 18,300 | $34.93 | 870,723 |
| 2010-12-08 | Option exercise (derivative) | 50,000 | $0.00 | 166,000 |
| 2010-12-08 | Option exercise (derivative) | 50,000 | $0.00 | 116,000 |
| 2010-12-08 | Option exercise (derivative) | 50,000 | $0.00 | 66,000 |
| 2010-12-08 | Open-market sale | 29,500 | $34.55 | 891,223 |
| 2010-12-08 | Option exercise | 50,000 | $15.81 | 970,723 |
| 2010-12-08 | Open-market sale | 50,000 | $34.01 | 920,723 |
| 2010-12-08 | Open-market sale | 50,000 | $33.85 | 970,723 |
| 2010-12-08 | Option exercise | 50,000 | $15.81 | 1,020,723 |
| 2010-12-07 | Option exercise (derivative) | 50,000 | $0.00 | 216,000 |
| 2010-12-07 | Option exercise (derivative) | 50,000 | $0.00 | 266,000 |
| 2010-12-07 | Option exercise | 50,000 | $15.81 | 1,020,723 |
| 2010-12-07 | Open-market sale | 43,700 | $34.25 | 970,723 |
| 2010-12-06 | Option exercise (derivative) | 31,600 | $0.00 | 31,600 |
| 2010-12-06 | Open-market sale | 6,300 | $34.11 | 1,014,423 |
| 2010-12-06 | Option exercise | 31,600 | $16.02 | 1,202,323 |
| 2010-12-06 | Open-market sale | 50,000 | $33.89 | 1,020,723 |
| 2010-12-06 | Open-market sale | 50,000 | $34.04 | 1,070,723 |
| 2010-12-06 | Open-market sale | 50,000 | $34.57 | 1,120,723 |
| 2010-12-06 | Open-market sale | 31,600 | $35.09 | 1,170,723 |
| 2010-06-16 | Open-market sale | 700,000 | $21.36 | 1,170,723 |
| 2010-06-08 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
| 2010-03-31 | Open-market sale | 15,427 | $23.35 | 1,870,723 |
| 2010-03-30 | Open-market sale | 38,811 | $23.36 | 1,886,150 |
| 2010-03-12 | Open-market sale | 136,735 | $22.32 | 1,924,961 |
| 2010-03-10 | Open-market sale | 5,014 | $21.62 | 2,061,696 |
| 2010-03-08 | Open-market sale | 38,106 | $21.62 | 2,066,710 |
| 2010-03-05 | Open-market sale | 2,700 | $21.62 | 2,104,816 |
| 2010-01-11 | Open-market sale | 15,985 | $21.62 | 2,107,516 |
| 2010-01-08 | Open-market sale | 4,499 | $21.62 | 2,123,501 |
| 2010-01-07 | Open-market sale | 200,000 | $20.00 | 2,328,000 |
| 2010-01-07 | Open-market sale | 200,000 | $20.70 | 2,128,000 |
| 2009-10-25 | Grant / award (derivative) | 63,200 | $0.00 | 63,200 |
| 2009-06-09 | Grant / award (derivative) | 200,000 | $0.00 | 200,000 |
| 2008-03-24 | Grant / award (derivative) | 625,000 | $0.00 | 625,000 |
| 2008-03-24 | Grant / award (derivative) | 625,000 | $0.00 | 625,000 |
| 2007-10-24 | — | — | — | 2,528,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.